Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196349 · ClinicalTrials.gov registry record · Phase 4
Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 44
- Enrollment target
NCT03196349: Clinical Trial Phase 4 study, sponsored by Duke University.
NCT03196349 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 44 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196349, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 44 participants
- Enrollment target
Study Summary
Comparison of Oral anticoagulants (warfarin, apixaban and rivaroxaban) for extended VEnous Thromboembolism.
Primary Outcome
Primary outcome of Clinically relevant bleeding (composite of major bleeding (MB) and/or clinically relevant non major bleeding (CRNMB))
Interventions
- DRUG Warfarin
- DRUG Apixaban 2.5 MG
- DRUG Rivaroxaban 10 MG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2019-05-01 |
| Phase | Phase 4 |
Why NCT03196349 stopped before completion
NCT03196349 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Warfarin is the first listed.
NCT03196349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03196349 about?
NCT03196349 is a clinical study titled "Comparison of Oral Anticoagulants for Extended VEnous Thromboembolism". Comparison of Oral anticoagulants (warfarin, apixaban and rivaroxaban) for extended VEnous Thromboembolism.
What is the current status of trial NCT03196349?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 44 participants. The study started on 2018-08-01. Estimated completion is 2019-05-01.
What interventions are being tested in trial NCT03196349?
The interventions under investigation include: Warfarin (DRUG), Apixaban 2.5 MG (DRUG), Rivaroxaban 10 MG (DRUG).
Who is sponsoring clinical trial NCT03196349?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03196349's enrollment target sits among peer trials
44 1363rd of 2000 higher than 630 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI